Crystalvue Medical Corporation (TPEX:6527)

Market Cap	1.88B -14.6%
Revenue (ttm)	905.73M +8.7%
Net Income	139.27M +20.3%
EPS	5.41 +19.5%
Shares Out	25.34M
PE Ratio	13.69
Forward PE	n/a
Dividend	2.25 (3.04%)
Ex-Dividend Date	Jul 24, 2025

Volume	10,270
Average Volume	12,968
Open	74.00
Previous Close	73.70
Day's Range	74.00 - 74.50
52-Week Range	68.60 - 93.00
Beta	0.90
RSI	37.03
Earnings Date	Mar 3, 2026

About Crystalvue Medical

Crystalvue Medical Corporation designs, produces, and sells medical devices worldwide. The company offers optical coherence tomography, retinal cameras, tonometers, lens edgers, and gastroenterology supplies, as well as ODM/OEM services for automated nucleic acid extraction instrument and PCR system. It also sells minimal invasive endoscopic instrument supplies. The company was founded in 2009 and is based in Taoyuan City, Taiwan.

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2009
• Employees: 109
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6527

Financial Performance

In 2024, Crystalvue Medical's revenue was 868.03 million, an increase of 5.35% compared to the previous year's 823.96 million. Earnings were 127.15 million, an increase of 22.98%.